CKD Treatment: Addressing Kidney and Cardiometabolic Outcomes Part 5: Chronic Heart Failure Management
The management of chronic heart failure in the setting of chronic kidney disease is an important topic, particularly for pharmacists, because the cornerstone for the treatment of heart failure is pharmacotherapy. Heart failure also remains the leading discharge diagnosis among patients greater than 65, and anywhere from 40 to 45% of individuals who have chronic heart failure also have some form of chronic kidney disease. In this module, we will cover the importance of guideline-directed medical therapy (GDMT), pharmacologic diuresis, and altering GDTM for those with CKD.
By the end of this module, learners will be able to:
- Discuss pharmacologic and non-pharmacologic strategies to monitor and maintain euvolemia in a patient with heart failure and CKD
- Apply guideline-directed medication management in a patients with heart failure and CKD
- Describe complications of guideline directed medical therapy for heart failure in a patient with CKD
Time: 60 minutes
The following planners and presenters have disclosed a financial relationship with an ineligible company:
- Katie Cardone, PharmD, BCACP, FNKF, FASN, FCCP - Grants/Research Support [Merck & Co], Consultant [Vifor, Otsuka], Honorarium [Pharmacy Times]
- Calvin Meaney, PharmD, BCPS - Speaker's Bureau [GSK], Consultant [GSK, Wolters-Kluwer (Lexicorp)]
- Wendy St. Peter, FCCP, FASN, FNKF - Consultant [GSK]
There are no conflicts of interest or financial relationships with an ineligible company that have been disclosed by the rest of the planners and presenters of this learning activity.
All relevant financial relationships have been mitigated.
In support of improving patient care, this activity is planned and implemented by The National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD). The OICPD is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians: The National Center for Interprofessional Practice and Education designates this live activity for 1 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with their participation.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
Nurses: Participants will be awarded 1 contact hour of credit for attendance in this module.
Nurse Practitioners: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Pharmacists: This activity is approved for 1 contact hour. UAN: JA4008105-9999-23-029-H01-P.
IPCE: This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.
